Results 131 to 140 of about 378,579 (303)

DSM-5 full syndrome, other specified, and unspecified eating disorders in Australian adolescents: prevalence and clinical significance

, 2019
Background: Little information is available on the prevalence of Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 eating disorders in adolescence, and eating disorders remain unique in the DSM for not systematically including a criterion ...
Bussey, K (15681077), Trompeter, N (15681074), Griffiths, S (15603782), Mitchison, D (15638924), Pike, KM (15685595), Hay, P (15527483), Jon Mond (14744557), Lonergan, A (15681080), Murray, SB (15638537)   +8 more
core  

The Japanese Adaptation of the Reading the Mind in Films Test: Differentiating Autism Spectrum Disorder From Depression Using an Ecologically Valid Social Cognitive Task

Autism Research, EarlyView.
ABSTRACT Cognitive tests that reflect the complexity of real‐world social interactions are essential for autism spectrum disorder (ASD)‐related clinical assessment and research. This study developed and adapted a Japanese version of the Reading the Mind in Films (RMF) test, which assesses mind‐reading ability through dynamic, multisensory, and context ...
Sayaka Kawakami, Shota Uono, Toshiya Murai, Sadao Otsuka   +3 more
wiley   +1 more source

EPVM-DSM

, 2000
Enhanced Parallel Virtual Machine - Distributed Shared Memory (EPVM-DSM) is a software extension of Parallel Virtual Machine (PVM) that provides shared memory primitives to the programmer.
Ong, Michelle G., Carlos, Charly Lester T., Cua, Zhen Kun O., Sy, Geoffrey C.   +3 more
core  

Psychological and Neurodevelopmental Correlates of Extreme Demand Avoidance in a Clinical Sample, an Exploratory Study

Autism Research, EarlyView.
ABSTRACT Extreme/pathological demand avoidance (EDA) is a behavioral profile characterized by the avoidance of everyday demands, with significant impact on the individuals and those around them. Little is understood regarding the correlates and drivers of EDA; understanding these better may lead to targeted interventions and support strategies.
Oliver Lack, Matthew J. Hollocks, Gillian Baird, Ann Ozsivadjian, Michael Absoud, Francesca Happé, Emily Simonoff   +6 more
wiley   +1 more source

Exploring new avenues: Psychedelic‐assisted therapy for young people

British Journal of Clinical Pharmacology, EarlyView.
Rates of mental illness in young people are increasing, whereas the development of novel mental health treatments has not significantly progressed. Psychedelic‐assisted therapy, using substances such as psilocybin and 3,4‐methylenedioxymethamphetamine (MDMA), has shown potential in the treatment of mental illnesses in the adult population, including ...
Ioanna Artemis Vamvakopoulou, Dasha Nicholls, David J. Nutt, Martina Di Simplicio   +3 more
wiley   +1 more source

Piattaforme UAV per applicazioni geomatiche

GEOmedia, 2012
Un’alternativa efficiente, veloce e low-cost al tradizionale rilievo aereo, ma ancora senza una regolamentazione chiara e con alcuni problemi di stabilità e payload.
Fabio Remondino, Francesco Nex, Daniele Sarazzi   +2 more
doaj  

Galileo and DSM [PDF]

CNS Spectrums, 2012
openaire   +2 more sources

Rocavorexant, a novel, selective orexin‐1 receptor antagonist: Safety, tolerability and pharmacokinetics in healthy adults and individuals with opioid use disorder

British Journal of Clinical Pharmacology, EarlyView.
Aims Rocavorexant (INDV‐2000), a selective orexin‐1 receptor antagonist, reduces drug self‐administration and anxiety in nonclinical studies. This Phase 1 programme evaluated the safety, pharmacokinetics and pharmacodynamics of rocavorexant in healthy volunteers and treatment‐seeking individuals with opioid use disorder (OUD).
Martin Kankam, Rana Al‐Awam, Rajinder Shiwach, Andrew S. Huhn, Malcolm A. Young, Robert L. Dobbins   +5 more
wiley   +1 more source

Glucagon‐like peptide‐1 receptor agonists in schizophrenia spectrum disorders: A systematic review and meta‐analysis of efficacy, safety and mental health outcomes

British Journal of Clinical Pharmacology, EarlyView.
Aims The purpose of this study is to evaluate efficacy, safety and mental‐health outcomes of glucagon‐like peptide‐1 (GLP‐1) receptor agonists in adults with overweight or obesity and antipsychotic‐treated schizophrenia‐spectrum disorders. Methods PubMed/MEDLINE, Embase, PsycINFO, CENTRAL, Virtual Health Library (VHL) (Biblioteca Virtual em Saúde, BVS),
Débora Regina de Aguiar, Samuel Izaias dos Santos Pereira, Pedro Batista Castro, Carlos Ricardo Oliveira Carneiro, Julia Costa de Araujo, Rebeca Ferreira de Souza, Otavio André Farias Sousa da Silva, Matheus Hissa Lourenço Ferreira, Bruna Loureiro Fontana Bolsoni, Nelson Carvas Junior, Mario Rodrigues Louzã   +10 more
wiley   +1 more source

Way Forward for Biomanufacturing and Biotechnology in Europe

CHIMIA
To restrict global warming to a maximum of 1.5 °C, greenhouse gas emissions need to be reduced to ‘net zero’ by 2050. The transition from the current, largely fossil-based global economy towards a circular, nowaste (bio-) economy based on renewable raw ...
Ulla Létinois, Steven Crump, Bastian Zerrer, Michael Hans, Pierre-Bertrand Meunier, Markus Wyss   +5 more
doaj   +1 more source